Origin of EpiLAB
The project was born during the first containment in March 2020. Clément Dubois connected with several SATT, a technology acceleration and transfer company, because he is interested in the valorisation of French technologies. From SATT Sayens, the EDMYC process "new portable and easy to use kit for tuberculosis diagnosis" hooked his attention. With the two technology inventors, and Maurice Lubetzki, former entrepreneur, Clement Dubois decided to take over the EDMYC patent and created EpiLAB.